Australia, July 23 -- DNAE Group Holdings Ltd., owns the trademark (2649921) for 'LIDIA-SEQ' till March 16, 2036.
Status: protected:
Registered/protected
Classes: 9 [Scientific apparatus and instruments; scientific research and laboratory apparatus; apparatus for conducting PCR analysis; apparatus for DNA and RNA amplification and sequencing for research purposes; apparatus for semiconductor sequencing; apparatus for on-chip DNA and RNA amplification sequencing and measurement; silicon transistors; microchips; data processing equipment; computer software; bioinformatics software; software for microbial pathogen detection and identification; computer software for the diagnosis of sepsis, infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; software for genetic sequence analysis for screening and detecting diseases and reporting of test results for healthcare professionals and patients; semiconductors and microchips for sequencing and measurement of DNA and RNA for scientific medical research and veterinary purposes; all for scientific research purposes.], 10 [Medical and veterinary apparatus and instruments; apparatus for providing diagnostic sequencing of blood samples, DNA and RNA; apparatus for microbial pathogen detection and identification; apparatus for the diagnosis and monitoring of sepsis and infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; apparatus for DNA and RNA testing for medical purposes; apparatus for the diagnosis and monitoring of cancer; apparatus for testing blood samples, cancer cells, DNA, RNA and protein; apparatus for PCR analysis and DNA and RNA sequencing for medical and veterinary purposes; medical diagnostic apparatus for taking and storing blood samples; vials and other containers in the nature of tubes for blood and other medical sample collection; single use cartridges for use in medical apparatus for analysing biological samples; medical diagnostic test kits for the detecting, analysis and monitoring of medical conditions; medical diagnostic apparatus for testing patient biological samples and monitoring of patients; semiconductors and microchips for sequencing and measurement of DNA and RNA for medical and veterinary purposes.], 42 [Scientific and technological services; laboratory services in the testing, sequencing and measurement of DNA and RNA; medical laboratory services; laboratory analysis; data storage services; software as a service (SaaS) services featuring software for genetic sequence analysis for screening and detecting diseases and reporting of test results for healthcare professionals and patients; consultancy and advisory services relating to the aforesaid services.] and 44 [Medical and veterinary services; healthcare services; DNA and RNA screening for medical purposes; genetic and blood testing, sequencing and measuring services; medical laboratory services for the analysis of samples taken from patients; provision of information relating to the analysis of DNA and RNA; genetic testing for medical purposes; genome sequencing and analysis services for medical and veterinary diagnostic and treatment purposes; medical diagnostic testing, monitoring and reporting services; consultancy and advisory services relating to the aforesaid services.]
Type of Mark: Word
Date of Acceptance: May 15
Registration Advertised: July 22
For further details contact Stratagem Intellectual Property Management Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2649921.
Disclaimer: Curated by HT Syndication.
